Bristol-Myers' Opdivo fails to meet lung cancer study goal

X Close www.yahoo.com

New Drugs, Faster Growth Have Upped This Company's Game

X Close www.investors.com

Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up

X Close www.xconomy.com

Bristol's Opdivo Fails In Lung Cancer Test — Will It Keep Its Approval?

X Close www.investors.com

BMS' Opdivo Flounders in Phase III Trial for Small Cell Lung Cancer

X Close www.biospace.com

Bristol-Myers stumbles in lung cancer quest as IO star Opdivo flunks small cell trial

X Close www.fiercepharma.com

Pharmalittle: FDA approves a record number of generics; Bristol-Myers' Opdivo fails lung cancer study goal

X Close www.statnews.com

Bristol-Myers concedes a PhIII lung cancer flop for Opdivo as competition heats up in SCLC

X Close endpts.com

Bristol-Myers Squibb Announces Phase 3 CheckMate -331 Study Does Not Meet Primary Endpoint of Overall Survival ...

X Close www.businesswire.com

Bristol-Myers Squibb Invests $12 Million in Israeli Immunotherapy Company Compugen

X Close www.calcalistech.com

BMS invests $12m in Compugen for tumor collaboration

X Close en.globes.co.il bos